Gerold Schmitt-Ulms
  • Faculty, Laboratory Medicine & Pathobiology, University of Toronto, Toronto
Research focus
  • Neuroscience
  • 1 Author merit
1 Protocol published
CRISPR-Cas9 technology has transformed the ability to edit genomic sequences and control gene expression with unprecedented ease and scale. However, precise genomic insertions of coding sequences using this technology remain time-consuming and ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.